Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (52)

2024

  1. Chronic Obstructive Lung Disease: Treatment Guidelines and Recommendations for Referral and Multidisciplinary Continuity of Care

    Journal of Clinical Medicine, Vol. 13, Núm. 2

  2. Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities

    Archivos de Bronconeumologia

  3. Current evidence for lung ultrasound elastography in the field of pneumology: a systematic review

    ERJ Open Research, Vol. 10, Núm. 4

  4. Integrating tabular data through image conversion for enhanced diagnosis: A novel intelligent decision support system for stratifying obstructive sleep apnoea patients using convolutional neural networks

    Digital Health, Vol. 10

  5. Malignant Pleural Effusion: A Multidisciplinary Approach

    Open Respiratory Archives, Vol. 6, Núm. 4

  6. Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Prediction of Dyspnea after 12 Months of an Acute Episode of COVID-19

    Biomedicines, Vol. 12, Núm. 4

  7. Proposal and Definition of an Intelligent Decision- Support System Based on Deep Learning Techniques for the Management of Possible COVID-19 Cases in Patients Attending Emergency Departments

    IEEE Access, Vol. 12, pp. 95035-95046

  8. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project

    Respiratory Research, Vol. 25, Núm. 1

  9. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry

    Archivos de Bronconeumologia

  10. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  3. Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

    Respiratory Research, Vol. 24, Núm. 1

  4. Exacerbations in COPD: a personalised approach to care

    The Lancet Respiratory Medicine

  5. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  6. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

  7. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  8. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. ANTES Program: One Year on

    Archivos de Bronconeumologia

  2. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1